Apolipoprotein A-1 (ApoA-1) is the primary structural and functional protein component of high-density lipoprotein (HDL) particles, accounting for approximately 70% of total HDL protein mass. It serves as a cofactor for lecithin-cholesterol acyltransferase (LCAT) and facilitates reverse cholesterol transport by mediating cholesterol efflux from peripheral tissues to the liver. ApoA-1 measurement provides a direct quantification of HDL particle functionality that may offer additional cardiovascular risk information beyond HDL-cholesterol alone. ApoA-1 is synthesized primarily in the liver and small intestine, and is secreted as a lipid-poor precursor that progressively acquires phospholipids and cholesterol to form mature HDL particles. It activates LCAT, which esterifies free cholesterol on HDL surfaces, enabling the reverse cholesterol transport pathway that removes excess cholesterol from arterial walls and delivers it to the liver for excretion. ApoA-1 also exerts anti-inflammatory, antioxidant, and endothelial-protective effects that contribute to its atheroprotective properties.
Apolipoprotein A-1 is the main protein found in 'good cholesterol' (HDL) particles. It helps remove excess cholesterol from your blood vessels and transport it to the liver for disposal, which protects against heart disease. Higher levels are generally a good sign for heart health, while lower levels may suggest a higher risk of cardiovascular problems. Your doctor may use this test alongside other cholesterol measurements to get a more complete picture of your heart health. Lifestyle factors like regular exercise and not smoking can help support healthy ApoA-1 levels.
When elevated: Elevated ApoA-1 levels are generally associated with a favorable cardiovascular risk profile, reflecting robust reverse cholesterol transport capacity and HDL functionality. Very high levels may occasionally be seen in certain genetic conditions such as familial hyperalphalipoproteinemia, which is usually benign. When low: Low ApoA-1 levels are associated with impaired reverse cholesterol transport, increased cardiovascular disease risk, and greater atherosclerotic burden. Significantly reduced levels may indicate rare genetic disorders such as Tangier disease or ApoA-1 deficiency, which carry markedly elevated cardiovascular risk.
ApoA-1 is relevant to athletes primarily as a marker of cardiovascular health and recovery quality rather than acute performance. Higher ApoA-1 levels reflect better HDL function and more efficient cholesterol clearance, which supports endothelial health and may aid recovery from training-induced oxidative stress; this is particularly meaningful for endurance athletes and those in sustained training blocks.
Turnaround Time
3 days (up to 7 days)
Fasting Required
No
Method
Immunologic
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$17.00$50
2.9× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$17.00
$23.00
$28.00
Peer-reviewed sources supporting the educational content on this page.
